Bottom line
FHCLX vs VHT: the short answer
FHCLX (Health Care Portfolio) and VHT (Vanguard Health Care Index Fund) are both mutual funds.
But VHT is far broader, holding 407 positions to 152 for FHCLX, so beyond the top names it adds exposure FHCLX doesn't have.
VHT is cheaper at 0.09% vs 0.91% — a difference of $82 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +4.0% for FHCLX (reporting dates differ).
Updated Nov 19, 2026
FHCLX vs VHT side by side
| FHCLX | VHT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.91% | 0.09% |
| Annual cost per $10k | $91 | $9 |
| 10-yr cost on $10k (prospectus) | $1,630 | $115 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +14.4% | +2.7% |
| 5-yr return (annualized) | +4.0% | +7.2% |
| 10-yr return (annualized) | +9.0% | +8.8% |
| Best quarter | +22.2% | +16.5% |
| Worst quarter | −15.0% | −13.1% |
| Net assets (fund) | $5.8B | $19.0B |
| Number of holdings | 152 | 407 |
| Portfolio turnover | 69% | 4% |
| Returns as of | Feb 28, 2026 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHCLX | VHT | Difference |
|---|---|---|---|
| 2024 | +4.9% | +2.7% | +2.3% |
| 2023 | +4.1% | +2.5% | +1.7% |
| 2022 | −12.8% | −5.5% | −7.3% |
| 2021 | +11.5% | +20.5% | −9.0% |
| 2020 | +24.4% | +18.2% | +6.2% |
| 2019 | +31.5% | +22.0% | +9.5% |
| 2018 | +7.4% | +5.6% | +1.9% |
| 2017 | +24.0% | +23.3% | +0.7% |
| 2016 | −10.7% | −3.3% | −7.4% |
Source: Fund prospectus bar charts
Holdings overlap
12 of FHCLX's top 25 holdings also appear in VHT's top 25.
| Holding | FHCLX | VHT |
|---|---|---|
| ELI LILLY and CO | 8.03% | 14.04% |
| Danaher Corp | 6.89% | 1.84% |
| JOHNSON and JOHNSON | 4.91% | 8.47% |
| Thermo Fisher Scientific Inc | 4.33% | 2.93% |
| Unitedhealth Group Inc | 3.49% | 5.45% |
| Gilead Sciences Inc | 2.21% | 2.64% |
| Boston Scientific Corp | 2.17% | 1.13% |
| Abbvie Inc | 2.03% | 6.09% |
| MERCK and CO INC | 1.60% | 4.66% |
| Cvs Health Corp | 1.29% | 1.83% |
| Cencora Inc | 1.14% | 0.79% |
| Edwards Lifesciences Corp | 1.09% | 0.79% |
Source: SEC Form N-PORT
FHCLX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
FAQ
What is the difference between FHCLX and VHT?
Which is cheaper, FHCLX or VHT?
Should I own both FHCLX and VHT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.